The University of Tokyo · Institute of Medical Science · 教授

Research keywords転移性大腸癌・胃癌補助化学療法・HER2陽性胃癌・食道癌化学放射線療法・膵癌タキサン療法・セツキシマブ療法・ベバシズマブ効果予測・S-1化学療法・腹膜転移癌細胞株

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Randomized, open-label, phase III study comparing irinotecan with paclitaxel in patients with advanced gastric cancer without severe peritoneal metastasis after failure of prior combination chemotherapy using fluoropyrimidine plus platinum: WJOG 4007 tria
• Association of renal function with the safety and efficacy of cisplatin plus S-1 therapy and docetaxel plus cisplatin plus S-1 therapy in patients with advanced gastric cancer: an exploratory analysis of JCOG1013
• A multi-center retrospective analysis of survival benefits of chemotherapy for unresectable biliary tract cancer
• A phase II study of biweekly mitomycin C and irinotecan combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group (JCOG0109-DI Trial)

• レセプト・健診の大規模データベースを活用した糖尿病の新規関連疾患に関する研究
• 生検組織を用いたリン酸化シグナル解析によるがん多様性機序の解明と精密医療への応用
• ＤＮＡ損傷修復経路における合成致死性を応用した乳癌の化学療法に関する研究
• 網羅的キナーゼ活性プロファイリングによるがん治療標的の探索研究

• Official profile